Sansure Biotech Inc. (688289.SS)

18.47 -0.03 (-0.16%) As of 11:29AM CST. Market open.

Sansure Biotech Inc.

No. 680, Lusong Road
High-tech Industrial Development Zone
Changsha 410205
China
86 731 8888 3176
https://www.sansure.com.cn

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Lizhong Dai	Chairman of the Board & GM	N/A	N/A	1968
Mr. Peng Zhu	CFO, Deputy GM, Board Secretary & Director	N/A	N/A	1975
Mr. Xialin Yu	Deputy GM & Director	N/A	N/A	1979
Mr. Xu Fan	Deputy GM & Director	N/A	N/A	1981
Mr. Jia Liu	Deputy GM & Director	N/A	N/A	1982
Mr. Zhongping Deng	Deputy General Manager	N/A	N/A	1977
Ms. Jun Zhou	Deputy General Manager	N/A	N/A	1971
Mr. Liu Kai	Deputy General Manager	N/A	N/A	1977
Mr. Jian Zhu	Deputy General Manager	N/A	N/A	1976
Mr. Haixiao Wang	Deputy General Manager	N/A	N/A	1978

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sansure Biotech Inc. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments in China. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests. The company also provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems. In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment advisory; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services. The company was founded in 2008 and is headquartered in Changsha, China.

Corporate governance

Sansure Biotech Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.